A startup company spun out of Johns Hopkins says it’s been able to slow the progression of Parkinson’s disease in mice models — and with a fresh infusion of cash, the company is taking the program into human trials.
High-profile investors led by billionaires Bill Gates and Leonard Lauder are throwing their weight behind a “venture philanthropy vehicle” offering more than $30 million in grants for new biomarkers and early diagnostic tests for Alzheimer’s disease.
The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, preparing several significant steps as one of the biggest U.S. drugmakers said it would bring down the cost of some medicines.
Johnson & Johnson Innovation LLC today announced agreement to launch the Johnson & Johnson Innovation, JLABS (JLABS) JPOD @ Philadelphia (JPOD @ Philadelphia) in collaboration with the University of Pennsylvania (Penn) to accelerate healthcare innovation and commercialization in Philadelphia and beyond.
With Tenable formally filing to go public in late June, observers are closely watching for updates to its Form S-1, which is required to be filed with U.S. Securities and Exchange Commission ahead of an IPO.
Montgomery County is turning over management of the Silver Spring Innovation Center to the recently-launched coworking division of a Maryland-based real estate company.
“It will take another 30 years for America to catch up to Montgomery County’s diversity.” – The New York Times
Algorithms used in a Spark Baltimore–based company’s software was recently patented for algorithms that will help it expand its presence in the market, according to its CEO.
MaxCyte announced that it has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to begin a clinical study in the United States with its first wholly-owned chimeric antigen receptor (CAR) therapeutic candidate, MCY-M11.
True Bearing Diagnostics Inc. is working to commercialize an early-detection test for coronary artery disease, a possible game-changer for the health care industry.